TXN is trading 118.7% above its estimated fair value, a level that flags significant overvaluation risk.
TXN fair value assessment
TXN is trading 118.7% above its estimated fair value, a level that flags significant overvaluation risk.
Reality vs. Belief
TXN's price is driven mostly by belief and is detached from its underlying fundamentals.
TXN signal snapshot
TXN projected price & trade signal
What's driving TXN's price
The story driving TXN right now: Texas Instruments (TXN) is poised for significant demand for its analog chips as robotics, driven by AI, emerges as the biggest opportunity within the AI supercycle. High volatility-momentum readings (98) indicate significant narrative-driven price displacement.
Market Prism's verdict on TXN
Market Prism flags TXN as Narrative Risk — the supporting story has structural weak points that raise the odds of a sharp repricing. Narrative energy is moderating at 54%, an early sign of fatigue.
Valuation outlook for TXN
Elevated narrative risk means the move is fragile. Watch for the first crack in the story — these names tend to reprice faster than the fundamentals change. The 118.7% fair-value deviation is extreme and, historically, tends to revert within 30–60 trading days.
Frequently asked questions
Is TXN overvalued right now?
TXN is trading 118.7% above its estimated fair value, a level that flags significant overvaluation risk.
What is Market Prism's verdict on TXN?
Market Prism flags TXN as Narrative Risk — the supporting story has structural weak points that raise the odds of a sharp repricing. Narrative energy is moderating at 54%, an early sign of fatigue.
What happens next for TXN?
Elevated narrative risk means the move is fragile. Watch for the first crack in the story — these names tend to reprice faster than the fundamentals change. The 118.7% fair-value deviation is extreme and, historically, tends to revert within 30–60 trading days.
Is TXN a good value investment?
Market Prism does not provide investment recommendations. Our forensic analysis shows: TXN is carrying elevated narrative risk, trading 118.7% above estimated fair value.